Knock-down of BCL6 / STAT6 sensitizes primary B cell lymphoma cells for treatment with current therapeutic agents

Primary mediastinal B cell lymphoma (PMBL) is characterized by specific molecular hallmarks including the expression of B Cell Lymphoma factor 6 (BCL6) and the presence of the activated Signal Transducers and Activators of Transcription factor 6 (STAT6). Recently we have shown that combined targetin...

Descripción completa

Detalles Bibliográficos
Autores principales: Häberle, Marie-Therese, Kelsch, Elena, Dorsch, Karola, Möller, Peter, Ritz, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278300/
https://www.ncbi.nlm.nih.gov/pubmed/25594020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278300/
https://www.ncbi.nlm.nih.gov/pubmed/25594020

Ejemplares similares